about
NS1 antigen detecting assays for diagnosing acute dengue infection in people living in or returning from endemic countriesDengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika VirusInteraction of a dengue virus NS1-derived peptide with the inhibitory receptor KIR3DL1 on natural killer cellsImmunogenic cross-talk between dengue and Zika virusesPeptide Vaccine: Progress and ChallengesUnderstanding the dengue viruses and progress towards their controlDengue E Protein Domain III-Based DNA Immunisation Induces Strong Antibody Responses to All Four Viral SerotypesArbovirosis and potential transmission blocking vaccinesDrivers of Inter-individual Variation in Dengue Viral Load DynamicsIdentification of a New Broadly Cross-reactive Epitope within Domain III of the Duck Tembusu Virus E ProteinHigh frequency of pre-existing neutralizing antibody responses in patients with dengue during an outbreak in Central BrazilGenomic approaches for understanding dengue: insights from the virus, vector, and hostDengue: an update on treatment optionsIdentifying Candidate Targets of Immune Responses in Zika Virus Based on Homology to Epitopes in Other Flavivirus SpeciesGalectin-1 exerts inhibitory effects during DENV-1 infectionIncomplete Protection against Dengue Virus Type 2 Re-infection in PeruThe Antigenic Structure of Zika Virus and Its Relation to Other Flaviviruses: Implications for Infection and ImmunoprophylaxisLack of Durable Cross-Neutralizing Antibodies Against Zika Virus from Dengue Virus InfectionRecurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico.Zika Virus: Recent Advances towards the Development of Vaccines and Therapeutics.Dengue induces platelet activation, mitochondrial dysfunction and cell death through mechanisms that involve DC-SIGN and caspasesCurrent progress in dengue vaccinesSubversion of early innate antiviral responses during antibody-dependent enhancement of Dengue virus infection induces severe disease in immunocompetent mice.Maternal Antibody-Mediated Disease Enhancement in Type I Interferon-Deficient Mice Leads to Lethal Disease Associated with Liver DamageDelineating antibody recognition against Zika virus during natural infectionSerotyping dengue virus with isothermal amplification and a portable sequencer.Burden of dengue infection and disease in a pediatric cohort in urban Sri Lanka.Utility, limitations, and future of non-human primates for dengue research and vaccine developmentDengue virus neutralizing antibody levels associated with protection from infection in thai cluster studies.Dengue vaccines: recent developments, ongoing challenges and current candidates.Seroprevalence of neutralizing antibodies against dengue virus in two localities in the state of Morelos, MexicoInduction of IFNα or IL-12 depends on differentiation of THP-1 cells in dengue infections without and with antibody enhancement.Isolation of dengue virus-specific memory B cells with live virus antigen from human subjects following natural infection reveals the presence of diverse novel functional groups of antibody clones.Variation of the specificity of the human antibody responses after tick-borne encephalitis virus infection and vaccination.Review article: Research on dengue during World War II revisited.Current perspectives on the spread of dengue in India.Prevalence and incidence of dengue virus and antibody placental transfer during late pregnancy in central Brazil.Dissection of antibody specificities induced by yellow fever vaccinationDengue virus type 1 clade replacement in recurring homotypic outbreaks.Role of humoral versus cellular responses induced by a protective dengue vaccine candidate.
P2860
Q24194181-5432EDCA-9C3B-4DC6-8147-C29561757C2EQ26247258-0B95160F-0349-4FF1-AFD2-ED9CA18290AEQ26314406-030F0E47-BE66-45F8-8ADD-7251A919D8E6Q26437328-6AA7C607-6518-493F-981B-EA36CE12C98FQ26851329-73F00E71-4B00-4952-8C1A-45328F03A913Q27011587-404DCFFD-FA5D-4B3B-9B77-CFFD45F7357DQ27304342-DBB67D46-6107-4C25-BC10-472A960906FFQ27468657-F98B6E18-40B4-4233-8207-437C1F690D9DQ27882968-90BFC91C-FD1D-4019-8AEC-8FE74B33C959Q27927982-9CFF25F0-D79C-4194-BDAD-3105B0C18270Q27928048-92681C34-D0AA-4E50-9C13-9305A9CCC400Q28073351-1B1D43C7-27A7-453B-9AD0-758941E44C02Q28085044-55129BCE-5730-4B67-8391-C2775FC287F7Q28119651-11D82BED-14CD-4847-9BD5-CED71F952EF2Q28544937-ED7CFBCA-A124-4CB1-AAE7-66357860D617Q28550030-5BF0FB8D-614A-4239-9F8A-056D5C16C82AQ28804225-209DEE5F-F269-4FB5-8130-D590C22B668EQ29051494-AF59A9EA-D0D4-434B-B689-4D1E43A91C1FQ30145646-201F07CE-8C02-462F-8121-269C04976EEAQ32183208-476392FB-FF31-49E2-A96B-3866CE17915CQ33406043-70E50D1F-776E-483A-AE02-4BC97F55727EQ33408300-16402C05-616C-4F29-A4BE-D7D7AB64ED84Q33414560-B5B34197-6C0F-482E-BCEE-898E95F6B465Q33430984-1638B0A6-578E-480E-90AC-A3D7D006511CQ33798068-43561A07-1B3F-42C3-B15D-DFCD372AEFFCQ33799483-2D98D5FB-26B5-4D3E-AF26-DD01F116947EQ33841059-348C4268-8A46-46CA-B2BD-7A2A4551D61CQ34238916-012756AF-6849-4E9A-A490-5BDA894352C8Q34351011-C7DCAD37-FB8B-4617-84AC-95C8761EF90DQ34367194-D5A33B78-9036-47FE-9C31-CFC04370F24CQ34496118-B764B241-7F0D-47A6-89A7-7D8EEFC972B3Q34502717-B926E759-5DEA-4B59-993A-DC03CD3C5A89Q34593818-3B1C47A8-4AB3-410D-B701-65CC8DF84757Q34594111-D73DF88A-9574-4846-8639-F009092C701BQ34640272-E1B4A15D-D9FC-4ED3-B5A7-5746F5B939A4Q34700783-74D022B4-9B6F-44A5-8A1A-1880BA428AAAQ34750747-2B54A12F-3390-437E-B282-55544EFC2208Q34789343-9F4C479D-373B-491F-8FD2-E522CBE1E14FQ35001225-26A6CBDE-3468-49AE-AF00-93F6C7855E42Q35034240-570247DF-EEC7-4AA5-BC9C-A6E550C6F178
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
The human antibody response to dengue virus infection
@en
The human antibody response to dengue virus infection.
@nl
type
label
The human antibody response to dengue virus infection
@en
The human antibody response to dengue virus infection.
@nl
prefLabel
The human antibody response to dengue virus infection
@en
The human antibody response to dengue virus infection.
@nl
P2860
P921
P356
P1433
P1476
The human antibody response to dengue virus infection
@en
P2093
Wahala M P B Wahala
P2860
P304
P356
10.3390/V3122374
P5008
P577
2011-11-25T00:00:00Z
2011-12-01T00:00:00Z